NEW YORK, April 16 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI - News), a specialty pharmaceutical company focused on niche drug-delivery technologies and products, reported today that the company’s Chairman and CEO, Jack Kachkar, M.D., reaffirmed to the special committee of the Inyx board of directors his all-cash offer priced at $3.01 per share to take the company private that was originally announced on March 26, 2007.
